Fluorescence spectroscopy was used to determine whether quinacrine and
ethidium, two high-affinity noncompetitive inhibitors of the Torpedo
acetylcholine receptor (AcChR), bind to the same loci. The ability of
three nitroxide spin-labels, 5-doxylstearate (5-SAL), spin-labeled and
rostane (ASL), and TEMPO, to quench receptor-bound quinacrine and ethi
dium fluorescence was measured. When bound to a phencyclidine-displace
able site on the AcChR, quinacrine was 16.9 and 19 times more efficien
tly quenched than ethidium by the highly lipophilic 5-SAL and ASL, res
pectively. TEMPO, which has a limited ability to partition into Torped
o plasma membranes (<1%), was only twice as efficient at quenching rec
eptor-bound quinacrine than ethidium fluorescence. The relative sensit
ivity of quinacrine and ethidium fluorescence to paramagnetic quenchin
g was examined in three solvents, 1-butanol, sodium phosphate buffer,
and acetonitrile, with TEMPO as a quencher. The results from the diffe
rent solvents demonstrate that quinacrine fluorescence is intrinsicall
y 1.4-3.6 times more sensitive than ethidium fluorescence to quenching
by nitroxide spin-labels. Examination of the effect of high concentra
tions of 5-SAL on ethidium and quinacrine dissociation constants showe
d that quinacrine but not ethidium binding was competitively inhibited
. Together, these results indicate that although quinacrine and ethidi
um bind in a mutually exclusive manner, the two inhibitors interact at
different loci on the AcChR. Whereas the ethidium binding site is at
a distance from membrane lipids, probably in or near the lumen, the qu
inacrine binding site appears to be at a lipid-protein interface in th
e transmembrane domain and at a distance from the lumen.